Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Blood Specimen Collection × Myeloid × Clear all

Status

Completed 8 Unknown 5 Recruiting 5 Active not recruiting 2 Withdrawn 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1 Head & Neck 1

Conditions

Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1

Interventions

olverembatinib 1 ibrutinib 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 Melphalan 1 JNJ-64619178 1 JNJ-64264681 1 Imatinib Mesylate 1 Busulfan 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡